Giovanni Cazzaniga

28PUBLICATIONS
150CO-AUTHORS
Haematological tumoursNeonatologyMedical molecular engineering of nucleic acids and proteinsMedical biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 10, 2026
Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia.

|Mar 12, 2026
Targeting oncogene-induced senescence in ETV6::RUNX1 pre-leukemic cells.

Denise Acunzo, Mayla Bertagna, Giulia Risca

|Aug 05, 2024
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia.

Michela Bardini, Grazia Fazio, Lilia Corral Abascal

|Aug 02, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression.

Belén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles

|Jan 12, 2024
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.

Barbara Buldini, Elena Varotto, Margarita Maurer-Granofszky

|Dec 14, 2023
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.

Valentino Conter, Maria Grazia Valsecchi, Gunnar Cario

Pageof 5

Frequent Collaborators

11 joint publications

Grazia Fazio

7 joint publications

Andrea Biondi

4 joint publications

Sabine Strehl

4 joint publications

Carmelo Rizzari